Drastic response of sunitinib after failure of Lenvatinib in patients with previously treated thymic carcinoma
Gespeichert in:
| Veröffentlicht in: | Lung cancer (Amsterdam, Netherlands) Netherlands), 2024-03, Vol.189, p.107501-107501, Article 107501 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 107501 |
|---|---|
| container_issue | |
| container_start_page | 107501 |
| container_title | Lung cancer (Amsterdam, Netherlands) |
| container_volume | 189 |
| creator | Kaira, Kyoichi Imai, Hisao Kagamu, Hiroshi |
| description | |
| doi_str_mv | 10.1016/j.lungcan.2024.107501 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2925484211</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0169500224000345</els_id><sourcerecordid>2925484211</sourcerecordid><originalsourceid>FETCH-LOGICAL-c313t-d9d0a83d4d069738890ff2717090358e5277d7194bfa3c54a5c3697594eea0413</originalsourceid><addsrcrecordid>eNqFkMtuEzEUQC1ERUPhE0BespngZ22vECotIEXqBtaWY9-hjmY8g-0Jyt_jMIEtK1_5nvs6CL2hZEsJvX1_2A5L-uFd2jLCRPtTktBnaEO1Yp3mnD1Hm8aZThLCrtHLUg6EUEWJeYGuueaCEaE3KH3KrtTocYYyT6kAnnpclhRrTHGPXV8h497FYcl_UjtIR7fmYsJzCyHVgn_F-oTnDMc4LWU44ZrBVQi4Pp3G1ty77GOaRvcKXfVuKPD68t6g7w_33-6-dLvHz1_vPu46zymvXTCBOM2DCOTWKK61IX3PFFXEEC41SKZUUNSIfe-4l8JJzxsojQBwRFB-g96tfec8_VygVDvG4mEYXIK2oWWGSaEFo2dUrqjPUykZejvnOLp8spTYs2p7sBfV9qzarqpb3dvLiGU_QvhX9ddtAz6sALRDjxGyLb7Z8hBiBl9tmOJ_RvwGlAuTJg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2925484211</pqid></control><display><type>article</type><title>Drastic response of sunitinib after failure of Lenvatinib in patients with previously treated thymic carcinoma</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Kaira, Kyoichi ; Imai, Hisao ; Kagamu, Hiroshi</creator><creatorcontrib>Kaira, Kyoichi ; Imai, Hisao ; Kagamu, Hiroshi</creatorcontrib><identifier>ISSN: 0169-5002</identifier><identifier>EISSN: 1872-8332</identifier><identifier>DOI: 10.1016/j.lungcan.2024.107501</identifier><identifier>PMID: 38342048</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>C-kit mutation ; Drastic response ; Humans ; Lenvatinib ; Lung Neoplasms ; Phenylurea Compounds ; Quinolines ; Sunitinib ; Sunitinib - therapeutic use ; Thymic carcinoma ; Thymoma - drug therapy ; Thymus Neoplasms - drug therapy</subject><ispartof>Lung cancer (Amsterdam, Netherlands), 2024-03, Vol.189, p.107501-107501, Article 107501</ispartof><rights>2024 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c313t-d9d0a83d4d069738890ff2717090358e5277d7194bfa3c54a5c3697594eea0413</cites><orcidid>0000-0001-5548-7686 ; 0000-0003-3097-4255 ; 0000-0003-4523-8517</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.lungcan.2024.107501$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38342048$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kaira, Kyoichi</creatorcontrib><creatorcontrib>Imai, Hisao</creatorcontrib><creatorcontrib>Kagamu, Hiroshi</creatorcontrib><title>Drastic response of sunitinib after failure of Lenvatinib in patients with previously treated thymic carcinoma</title><title>Lung cancer (Amsterdam, Netherlands)</title><addtitle>Lung Cancer</addtitle><subject>C-kit mutation</subject><subject>Drastic response</subject><subject>Humans</subject><subject>Lenvatinib</subject><subject>Lung Neoplasms</subject><subject>Phenylurea Compounds</subject><subject>Quinolines</subject><subject>Sunitinib</subject><subject>Sunitinib - therapeutic use</subject><subject>Thymic carcinoma</subject><subject>Thymoma - drug therapy</subject><subject>Thymus Neoplasms - drug therapy</subject><issn>0169-5002</issn><issn>1872-8332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtuEzEUQC1ERUPhE0BespngZ22vECotIEXqBtaWY9-hjmY8g-0Jyt_jMIEtK1_5nvs6CL2hZEsJvX1_2A5L-uFd2jLCRPtTktBnaEO1Yp3mnD1Hm8aZThLCrtHLUg6EUEWJeYGuueaCEaE3KH3KrtTocYYyT6kAnnpclhRrTHGPXV8h497FYcl_UjtIR7fmYsJzCyHVgn_F-oTnDMc4LWU44ZrBVQi4Pp3G1ty77GOaRvcKXfVuKPD68t6g7w_33-6-dLvHz1_vPu46zymvXTCBOM2DCOTWKK61IX3PFFXEEC41SKZUUNSIfe-4l8JJzxsojQBwRFB-g96tfec8_VygVDvG4mEYXIK2oWWGSaEFo2dUrqjPUykZejvnOLp8spTYs2p7sBfV9qzarqpb3dvLiGU_QvhX9ddtAz6sALRDjxGyLb7Z8hBiBl9tmOJ_RvwGlAuTJg</recordid><startdate>202403</startdate><enddate>202403</enddate><creator>Kaira, Kyoichi</creator><creator>Imai, Hisao</creator><creator>Kagamu, Hiroshi</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5548-7686</orcidid><orcidid>https://orcid.org/0000-0003-3097-4255</orcidid><orcidid>https://orcid.org/0000-0003-4523-8517</orcidid></search><sort><creationdate>202403</creationdate><title>Drastic response of sunitinib after failure of Lenvatinib in patients with previously treated thymic carcinoma</title><author>Kaira, Kyoichi ; Imai, Hisao ; Kagamu, Hiroshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c313t-d9d0a83d4d069738890ff2717090358e5277d7194bfa3c54a5c3697594eea0413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>C-kit mutation</topic><topic>Drastic response</topic><topic>Humans</topic><topic>Lenvatinib</topic><topic>Lung Neoplasms</topic><topic>Phenylurea Compounds</topic><topic>Quinolines</topic><topic>Sunitinib</topic><topic>Sunitinib - therapeutic use</topic><topic>Thymic carcinoma</topic><topic>Thymoma - drug therapy</topic><topic>Thymus Neoplasms - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kaira, Kyoichi</creatorcontrib><creatorcontrib>Imai, Hisao</creatorcontrib><creatorcontrib>Kagamu, Hiroshi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Lung cancer (Amsterdam, Netherlands)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kaira, Kyoichi</au><au>Imai, Hisao</au><au>Kagamu, Hiroshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drastic response of sunitinib after failure of Lenvatinib in patients with previously treated thymic carcinoma</atitle><jtitle>Lung cancer (Amsterdam, Netherlands)</jtitle><addtitle>Lung Cancer</addtitle><date>2024-03</date><risdate>2024</risdate><volume>189</volume><spage>107501</spage><epage>107501</epage><pages>107501-107501</pages><artnum>107501</artnum><issn>0169-5002</issn><eissn>1872-8332</eissn><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>38342048</pmid><doi>10.1016/j.lungcan.2024.107501</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-5548-7686</orcidid><orcidid>https://orcid.org/0000-0003-3097-4255</orcidid><orcidid>https://orcid.org/0000-0003-4523-8517</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0169-5002 |
| ispartof | Lung cancer (Amsterdam, Netherlands), 2024-03, Vol.189, p.107501-107501, Article 107501 |
| issn | 0169-5002 1872-8332 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2925484211 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | C-kit mutation Drastic response Humans Lenvatinib Lung Neoplasms Phenylurea Compounds Quinolines Sunitinib Sunitinib - therapeutic use Thymic carcinoma Thymoma - drug therapy Thymus Neoplasms - drug therapy |
| title | Drastic response of sunitinib after failure of Lenvatinib in patients with previously treated thymic carcinoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T13%3A40%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drastic%20response%20of%20sunitinib%20after%20failure%20of%20Lenvatinib%20in%20patients%20with%20previously%20treated%20thymic%20carcinoma&rft.jtitle=Lung%20cancer%20(Amsterdam,%20Netherlands)&rft.au=Kaira,%20Kyoichi&rft.date=2024-03&rft.volume=189&rft.spage=107501&rft.epage=107501&rft.pages=107501-107501&rft.artnum=107501&rft.issn=0169-5002&rft.eissn=1872-8332&rft_id=info:doi/10.1016/j.lungcan.2024.107501&rft_dat=%3Cproquest_cross%3E2925484211%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2925484211&rft_id=info:pmid/38342048&rft_els_id=S0169500224000345&rfr_iscdi=true |